Arq Bras Endocrinol Metab 2012;56(5):338-340
Ablation of thyroid remnant with 30 mCi 131I in thyroid cancer patients prepared with recombinant human TSH
DOI: 10.1590/S0004-27302012000500011
DOI: 10.1590/S0004-27302012000500011
Flow diagram of patient exclusion criteria for SNMTC and FNMTC groups.
Rosário PW. Ablation of thyroid remnant with 30 mCi 131I in thyroid cancer patients prepared with recombinant human TSH. Arq Bras Endocrinol Metab 2012;56(5):338-40.
Rosário, Pedro Weslley. Ablation of thyroid remnant with 30 mCi 131I in thyroid cancer patients prepared with recombinant human TSH. Arq Bras Endocrinol Metab, v. 56, n. 5, p. 338-340, Jul. 2012.
Rosário, P. W. (2012). Ablation of thyroid remnant with 30 mCi 131I in thyroid cancer patients prepared with recombinant human TSH. Arq Bras Endocrinol Metab, 56(5), 338-340.
Rosário, Pedro Weslley. Ablation of thyroid remnant with 30 mCi 131I in thyroid cancer patients prepared with recombinant human TSH. Arq Bras Endocrinol Metab [online]. 2012, vol. 56, n. 5, [cited 2026-03-09], pp.338-340. Available from: <https://www.aem-sbem.com/article/ablation-of-thyroid-remnant-with-30-mci-131i-in-thyroid-cancer-patients-prepared-with-recombinant-human-tsh/>. ISSN 2359-3997.